Logo
x

Search

Subscribe Now

Expanded

Quidel's Lyra SARS-CoV-2 Assay Receives the US FDA's Expanded Emergency Use Authorization for Molecular Detection of COVID-19

Quidel's Lyra SARS-CoV-2 Assay Receives the US FDA's Expanded Emergency Use Authorization for Molecular Detection of COVID-19

  • March 27, 2020
LEO Pharma's Enstilar Foam and Taclonex Topical Suspension Receive the US FDA's Expanded Approval for Plaque Psoriasis

LEO Pharma's Enstilar Foam and Taclonex Topical Suspension Receive the US FDA's Expanded Approval for Plaque Psoriasis

  • August 1, 2019
Roche's Kadcyla (trastuzumab emtansine) Receives FDA's Expanded Approval as an Adjuvant Treatment for HER2+ Early Breast Cancer in the US

Roche's Kadcyla (trastuzumab emtansine) Receives FDA's Expanded Approval as an Adjuvant Treatment for HER2+ Early Breast Cancer in...

  • May 6, 2019
Merck's Keytruda (pembrolizumab) Receives FDA's Expanded Monotherapy Label Approval for Patients with 1L Stage III Non-Small Cell Lung Cancer (NSCLC)

Merck's Keytruda (pembrolizumab) Receives FDA's Expanded Monotherapy Label Approval for Patients with 1L Stage III Non-Small Cell...

  • April 12, 2019
Abbott's MitraClip Device Receives FDA's Expanded Indication Approval for Secondary Mitral Regurgitation (MR)

Abbott's MitraClip Device Receives FDA's Expanded Indication Approval for Secondary Mitral Regurgitation (MR)

  • March 15, 2019
Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA's Approval for Expanded Indication for Chronic Total Occlusion (CTO)

Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA's Approval for Expanded Indication for Chronic Total Occlusion (...

  • February 27, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.